Royalty Pharma Plc (RPRX)
45.46
+0.34
(+0.76%)
USD |
NASDAQ |
Feb 23, 16:00
45.46
0.00 (0.00%)
After-Hours: 19:59
Royalty Pharma Market Cap : 19.48B for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Denali Therapeutics, Inc. | 3.259B |
| PTC Therapeutics, Inc. | 5.657B |
| Veru, Inc. | 36.35M |
| Incyte Corp. | 20.07B |
| Vertex Pharmaceuticals, Inc. | 122.20B |
Market Cap Related Metrics
| PE Ratio | 25.53 |
| PS Ratio | 10.17 |
| Price to Book Value | 3.007 |
| Price to Free Cash Flow | 26.97 |
| Price | 45.46 |
| Earnings Yield | 3.92% |
| Operating PE Ratio | 15.52 |
| Normalized PE Ratio | 26.34 |